Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

| More on:

Young African Businesswoman Analyzing Data On Multiple Computer Screen In Office

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

Gold Road Resources Ltd (ASX: GOR)

According to a note out of Goldman Sachs, its analysts have retained their buy rating on this gold miner's shares with a slightly trimmed price target of $1.95. This follows the release of the company's quarterly update. Goldman notes that much of the update was pre-released, so there were not many surprises. And while the wet weather impact has disappointingly led to management guiding to production at the low end of its guidance range and costs at the high end of its guidance range, the broker remains positive. Particularly given its valuation. Goldman highlights that Gold Road's shares are trading at ~0.9x net asset value compared to its peers at 1.3x net asset value. It also has near-term free cash flow yields of 5% to 10% through to FY 2026. The Gold Road share price is trading at $1.61 on Monday.

NextDC Ltd (ASX: NXT)

A note out of Morgans reveals that its analysts have retained their add rating and $19.00 price target on this data centre operator's shares. This follows the completion of the company's institutional entitlement offer which raised $937 million. It believes this leaves NextDC well-positioned for growth over the coming years. Especially as artificial intelligence drives another wave of demand for capacity in data centres. The broker is so positive on the company's outlook that it sees scope for its shares to be trading around the $40 mark at the start of the next decade. For now, the NextDC share price is fetching $15.84 this afternoon.

ResMed Inc. (ASX: RMD)

Another note out of Morgans reveals that its analysts have retained their add rating and $32.82 price target on this sleep disorder treatment company's shares. The broker notes that Eli Lilly & Co (NYSE: LLY) has released positive trial results from its weight loss wonder drug in the treatment of sleep apnoea. However, Morgans doesn't see this as a negative. As well as expecting only a negligible impact on the market, it feels the drugs are likely to support its expansion. As a result, it remains very bullish on the company's outlook. The ResMed share price is trading at $28.00 on Monday.

Motley Fool contributor James Mickleboro has positions in Nextdc and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A cool young man walking in a laneway holding a takeaway coffee in one hand and his phone in the other reacts with surprise as he reads the latest news on his mobile phone
Broker Notes

Morgans says these ASX stocks can rise 20% (and pay big dividends!)

The broker believes some very big returns could be on the cards over the next 12 months.

Read more »

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

happy investor, share price rise, increase, up
Broker Notes

These ASX 200 shares could rise 15% to 50%

Analysts think these shares can rise strongly from where they trade today.

Read more »

a man peers through a broken brick wall to see grey clouds gathering beyond it
Share Market News

Why this smashed ASX 200 share is a fundie's top value pick

It's an ASX consumer discretionary stock that has lost 40% of its value over the past year.

Read more »

Happy man working on his laptop.
Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Resources Shares

Up 51% from their 52-week low, is it too late to buy Mineral Resources shares?

Mineral Resources has been on a tear since mid-January. Do these top brokers think it's too late to buy?

Read more »

A laughing woman pushes her friend, who has her arms outstretched, in a supermarket trolley.
Retail Shares

Goldman says these 6 ASX retail shares are a buying opportunity

The latest retail trading data was historically weak, according to the Australian Bureau of Statistics.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

Buy, hold or sell these 3 ASX 200 healthcare shares: Experts

These experts reveal their calls on CSL, Resmed and Sonic Healthcare shares today.

Read more »